- Home
- IH vs NMRA Comparison
IH vs NMRA Comparison
Compare IH & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IH
- NMRA
- Stock Information
- Founded
- IH 1996
- NMRA 2019
- Country
- IH China
- NMRA United States
- Employees
- IH N/A
- NMRA N/A
- Industry
- IH Other Consumer Services
- NMRA
- Sector
- IH Real Estate
- NMRA
- Exchange
- IH Nasdaq
- NMRA Nasdaq
- Market Cap
- IH 123.1M
- NMRA 112.8M
- IPO Year
- IH 2020
- NMRA 2023
- Fundamental
- Price
- IH $2.38
- NMRA $0.72
- Analyst Decision
- IH
- NMRA Buy
- Analyst Count
- IH 0
- NMRA 8
- Target Price
- IH N/A
- NMRA $9.29
- AVG Volume (30 Days)
- IH 10.6K
- NMRA 846.2K
- Earning Date
- IH 06-27-2025
- NMRA 05-12-2025
- Dividend Yield
- IH 3.57%
- NMRA N/A
- EPS Growth
- IH N/A
- NMRA N/A
- EPS
- IH 0.25
- NMRA N/A
- Revenue
- IH $126,344,481.00
- NMRA N/A
- Revenue This Year
- IH $39.02
- NMRA N/A
- Revenue Next Year
- IH N/A
- NMRA N/A
- P/E Ratio
- IH $9.65
- NMRA N/A
- Revenue Growth
- IH N/A
- NMRA N/A
- 52 Week Low
- IH $1.47
- NMRA $0.61
- 52 Week High
- IH $3.18
- NMRA $17.19
- Technical
- Relative Strength Index (RSI)
- IH 56.54
- NMRA 46.83
- Support Level
- IH $2.25
- NMRA $0.66
- Resistance Level
- IH $2.39
- NMRA $0.73
- Average True Range (ATR)
- IH 0.12
- NMRA 0.06
- MACD
- IH -0.00
- NMRA 0.02
- Stochastic Oscillator
- IH 71.54
- NMRA 63.82
About IH iHuman Inc.
iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources.
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.